karyotype

Related by string. karyotypes * * normal karyotype *

Related by context. All words. (Click for frequent words.) 68 morphologic 67 microsatellite instability 67 histopathologic 66 autosomal 66 karyotypes 66 chromosomal aberrations 66 allelic 66 immunohistochemical staining 65 lymph node metastasis 65 monozygotic twins 65 fig. S1 65 thyroglobulin 65 aneuploid 65 mosaicism 65 PTPN# 64 FDG uptake 64 Doppler sonography 64 hamartomas 64 immunohistochemical 64 somatic mutations 64 p# mutation 64 hamartoma 64 allele frequencies 64 karyotyping 64 Histologic 64 VNTR 63 indel 63 histologic 63 FMR1 63 phenotypically 63 normal karyotype 63 Figure 2C 63 Supplementary Table 63 orthologs 63 ventricular myocardium 63 immunostaining 63 #p# [003] 63 homozygote 63 genomewide 63 C#BL/#J 63 echogenicity 63 homozygotes 63 penetrance 63 MMP# 63 prostate carcinoma 63 teratoma 63 neoplasm 63 inhibin 63 nodal metastases 63 homozygosity 63 #S rRNA 63 histopathological 63 miRNA expression 63 cytologic 63 clinicopathologic 63 methylenetetrahydrofolate reductase 62 frameshift mutation 62 somatic mutation 62 microdeletions 62 mucinous 62 fig. S2 62 Fig. 3b 62 adnexal mass 62 metaplasia 62 transgene expression 62 Supplementary Fig 62 gene amplification 62 #p# [001] 62 chromosomal deletions 62 monozygotic 62 heterozygous 62 heterozygosity 62 aneuploidies 62 methylation patterns 62 #q#.# [001] 62 missense mutations 62 PALB2 62 mutant allele 62 TCF#L# gene 62 Phylogenetic analysis 62 HRCT 62 Fig. 2b 62 heterozygotes 62 histologically 62 mutant alleles 62 Fig. 1D 62 de novo mutations 62 histopathologic examination 62 rs# [002] 62 rs# [004] 62 gadolinium enhanced 62 Prenatal diagnosis 62 paternally inherited 62 lesional 62 MC1R 62 immunohistochemical analysis 62 supratentorial 61 cellularity 61 ASCUS 61 TMPRSS2 ERG fusion 61 transvaginal sonography 61 #S rRNA gene 61 differentially expressed genes 61 immunoreactivity 61 microRNA expression 61 sonographically 61 hepatocellular carcinomas 61 variant allele 61 hyperplastic 61 Immunohistochemical staining 61 phenotype 61 rs# [001] 61 histological subtype 61 cytochrome b 61 nodal metastasis 61 serovar 61 epididymal 61 pleomorphic 61 dizygotic twins 61 prognostic factor 61 mRNA expression 61 MSH2 61 IgA deficiency 61 colocalization 61 malignant nodules 61 subcellular localization 61 virulence genes 61 metastatic lesion 61 ultrasonographic 61 alleles 61 scintigraphic 61 H#K#me# 61 microdeletion 61 #q#.# [002] 61 DNA methylation patterns 61 #S rRNA genes 61 transmembrane protein 61 chromosome #q#.# [001] 61 miRNAs miR 61 PCR amplified 61 CagA 61 mRNA transcripts 60 hyperintensity 60 ploidy 60 syngeneic 60 autosomes 60 nucleotide substitutions 60 MECP2 gene 60 monozygotic twin 60 #p#.# [001] 60 cTnT 60 chromosome #q# [002] 60 chromosome #q# [001] 60 FGFR2 gene 60 sonographic appearance 60 biopsy specimen 60 leiomyoma 60 CGG repeats 60 gastric carcinoma 60 PTEN gene 60 functional polymorphism 60 sequence homology 60 lymphoid cells 60 microcephalin 60 Immunohistochemical analysis 60 S. cerevisiae 60 RT PCR assay 60 fig. S4 60 MLH1 60 MTHFR gene 60 transabdominal 60 intronic 60 genetic loci 60 luminal 60 allele frequency 60 TOP2A gene 60 lymphocytic 60 ^ sup #m 60 CFTR gene 60 K#N 60 hypermethylated 60 #p#.# [002] 60 phenotypic characteristics 60 LVNC 60 sporadic ALS 60 Histopathologic 60 Leydig cell 60 germline mutations 60 Trichophyton rubrum 60 aneuploidy 60 evolutionarily conserved 60 Figure 1A 60 5q 60 ultrastructural 60 RRM1 60 mtDNA 60 CDH1 60 Fig. 3a 60 histologic examination 60 histologic findings 60 COL#A# 60 Prox1 60 proto oncogene 60 morphologically 60 breast carcinoma 60 infarcts 60 chromosome #q#.# [002] 60 breast carcinomas 60 chorionic villi 60 biopsy specimens 60 Cytogenetic 60 C#BL 6 60 FMR1 gene 60 array CGH 60 indels 60 aCGH 59 ABCB1 59 breast cancer subtypes 59 diffusion tensor 59 chromosomal rearrangements 59 thyroid carcinoma 59 SMAD4 59 GFP fluorescence 59 NF1 gene 59 X chromosome inactivation 59 leukocytosis 59 phylogenetically 59 TIMP 59 KRAS mutations 59 paragangliomas 59 beta globin 59 ADRB2 59 osteochondroma 59 mammographic density 59 BARD1 59 segmental duplications 59 genome rearrangements 59 genomic deletions 59 MYBPC3 59 dizygotic 59 K ras gene 59 C#T [002] 59 isoenzyme 59 cytokeratin 59 ERBB2 59 allelic variants 59 telomere lengths 59 gene expression patterns 59 Rh factor 59 clonal expansion 59 clinicopathological 59 histologic subtype 59 CYP#D# gene 59 morphometric analysis 59 proximal colon 59 peritumoral 59 cardiac troponin 59 tumor biopsies 59 mitochondrial DNA mtDNA 59 FGFR2 59 Computed tomography 59 CIN2 + 59 isoform 59 3'UTR 59 sonographic examination 59 bronchoalveolar lavage 59 monogenic 59 situs inversus 59 chromosomal alterations 59 cTnI 59 nucleotide substitution 59 histopathologic findings 59 allelic variation 59 D. melanogaster 59 MLL gene 59 lymph node metastases 59 K ras mutations 59 coexpression 59 Fig. 1C 59 hippocampal neurons 59 chromosomal mutations 59 prognostic significance 59 chromosomal rearrangement 59 SNP rs# [002] 59 multivariable analysis 59 sCJD 59 CHD7 59 myometrium 59 inbred strains 59 autoregulation 59 neoplastic 59 TOP2A 59 pancreatic adenocarcinoma 59 Papillary 59 morphometric 59 Figure 1C 59 leiomyomas 59 quantitative trait loci 59 Histologically 59 microvessel 59 HepG2 cells 59 intraobserver 59 C#Y 59 gene rearrangements 59 NR#A# 59 lymph node involvement 59 BDNF gene 59 MAPK pathway 59 glomerular 59 intracytoplasmic 59 familial aggregation 59 methyltransferase 59 urine cytology 59 neoplastic cells 59 atherosclerotic lesion 59 qRT PCR 59 fluorescence intensity 59 premutation 59 ALK mutations 59 receptor gene 59 SNP rs# [001] 59 pathogenic mutations 59 nucleotide sequence 59 SNe Ia 59 neoplastic lesions 59 haplotype 59 hypothalamic pituitary 59 promoter methylation 59 genomically 59 GISTs 59 gene locus 59 suppressor gene 58 villous 58 urothelial carcinoma 58 CHEK2 58 F FDG uptake 58 single nucleotide polymorphism 58 transgenic mice expressing 58 MC1R gene 58 PON1 58 subtype 58 proband 58 differential gene expression 58 genotypic 58 chromosomal anomalies 58 parasitaemia 58 ependymomas 58 orthologous 58 extramedullary 58 xenograft tumors 58 p# mutations 58 invasive ductal 58 X inactivation 58 globin genes 58 perfusion defect 58 polymorphism 58 dinucleotide 58 tyrosine phosphorylation 58 p# biomarker 58 Estrogen Receptor 58 interobserver reliability 58 PCR RFLP 58 melanocyte 58 BRCA mutation carriers 58 paraganglioma 58 amino acid substitutions 58 lung adenocarcinomas 58 polypoid 58 chimp genomes 58 kilobase 58 HER2 expression 58 PrPSc 58 dysgenesis 58 2n = 58 Multivariate analysis 58 F FDG PET 58 logistic regression analysis 58 alternatively spliced 58 KCNE2 58 phylogenetic analyzes 58 intact parathyroid hormone 58 stratifying patients 58 C1q 58 FXTAS 58 tumoral 58 T1a 58 liver metastasis 58 APOE e4 58 ribosomal protein 58 ORFs 58 osteoid 58 uniparental 58 cathepsin B 58 multivariate analyzes 58 diploid 58 autosomal dominant 58 APOC3 58 fibrous dysplasia 58 GSTP1 58 diagnostic biomarker 58 quasispecies 58 colorectal tumor 58 paralogs 58 SHANK3 58 situ hybridization 58 mitochondrial genome 58 monoclonal gammopathy 58 tumor histology 58 linkage disequilibrium 58 papillary renal cell carcinoma 58 interobserver 58 Fig. 1E 58 bronchoalveolar lavage BAL 58 endometrial biopsy 58 Fig. 2C 58 striated muscle 58 haematopoietic 58 adenoma 58 atypical hyperplasia 58 immunofluorescence staining 58 anterior pituitary 58 multiple logistic regression 58 EBNA1 58 gastric adenocarcinoma 58 NFKBIA 58 cutaneous lesions 58 estrogen receptor ER 58 microglial 58 cAMP signaling 58 TT genotype 58 epigenetic modification 58 HbF 58 preoperative PSA 58 p tau 58 B7 H3 58 TP# gene 58 lymphocytosis 58 δ 58 transcriptional profiles 58 cysteines 58 κ 58 CC genotype 58 constitutively active 58 trabecular bone 58 phenotypic expression 58 HIV tropism 58 Supplemental Figure 58 fraternal twin pairs 58 abnormal cytology 58 TYMS 58 ventilation perfusion 58 p# Shc 58 hypointense 58 GSTT1 58 extracolonic 58 germline 58 corpus luteum 58 intestinal metaplasia 58 immunofluorescent 58 thyrotropin 58 TUNEL 58 SMN2 gene 58 autosomal recessive 58 coding genes 58 periventricular 58 germline mutation 58 endometrioid 58 hypomethylation 58 angiographically 58 Fig. 1b 58 apolipoproteins 58 genes differentially expressed 58 sonographic findings 58 Histopathologic examination 58 Western blotting 58 homodimer 58 MTHFR 58 #q# [001] 58 A. thaliana 58 P cadherin 57 adiponectin concentrations 57 pelvic ultrasound 57 molecular abnormalities 57 #q# [002] 57 immunodominant 57 mCi 57 Jhdm2a 57 epithelia 57 inherited maternally 57 fetal echocardiography 57 gene polymorphism 57 multivariate Cox 57 metastatic lesions 57 oncologic outcomes 57 p# MAPK 57 colorectal carcinoma 57 C. neoformans 57 apolipoprotein E gene 57 Klinefelter syndrome 57 K#R [002] 57 hemagglutinin gene 57 plain radiographs 57 chromosome #p# [001] 57 ligand receptor 57 thymocytes 57 conserved sequences 57 quantitative RT PCR 57 OPRM1 gene 57 paraneoplastic 57 hypogonadotropic hypogonadism 57 figs. 57 chromosomal DNA 57 chromosomal abnormalities 57 57 fractional anisotropy 57 troponins 57 allele 57 RT qPCR 57 coding exons 57 RQ PCR 57 D#N 57 TRUS 57 HLA DQ 57 HER2 gene 57 protein isoforms 57 immunocytochemistry 57 operable breast cancer 57 epistasis 57 prostate cancer CaP 57 amplicons 57 nucleotide variations 57 HMGA2 57 PCa 57 Histological examination 57 inhibin B 57 pairwise comparisons 57 intron 57 epithelial tumors 57 CCR5 delta# 57 condensin 57 carcinoid tumor 57 HCT# 57 echocardiographic 57 antiphospholipid antibodies 57 ROC curves 57 Histological 57 IL#B 57 PIB PET 57 histologic subtypes 57 ductal lobular 57 etiologic 57 rCBF 57 transcriptional repressor 57 hepatoma 57 FGFR3 57 histopathological examination 57 gene expression profiles 57 cytogenetic abnormalities 57 catechol O methyltransferase 57 human leukocyte antigens 57 proteomic analysis 57 cystatin 57 VHL gene 57 bacterial genomes 57 troponin T 57 TP# mutations 57 ERK signaling 57 hyperplastic polyps 57 p# p# 57 T2 weighted images 57 CYP#D# genotype 57 gene polymorphisms 57 melanocytic nevi 57 #q# deletion 57 homozygous 57 succinate dehydrogenase 57 multigenic 57 amplicon 57 NSCLC tumors 57 HLA DR 57 UGT#A# * 57 susceptibility gene 57 logistic regression analyzes 57 endophenotypes 57 SLNB 57 hypoechoic 57 ortholog 57 haplotypes 57 ZNF# 57 gene APOE 57 transfusion syndrome 57 homolog 57 cone photoreceptors 57 kidney allograft 57 amino acid residues 57 fig. S# 57 Sagittal 57 hematoxylin 57 hyperintensities 57 Kruskal Wallis test 57 histological 57 metabolomic profiles 57 splice variant 57 clonogenic 57 methylation markers 57 BCL#A 57 intergenic 57 ductus venosus 57 HLA B# 57 color Doppler sonography 57 thyroid nodule 57 chromosomal instability 57 chromosomal disorders 57 Bonferroni correction 57 SUVmax 57 thymocyte 57 unmutated 57 pathologic examination 57 independent prognostic marker 57 pathologic diagnosis 57 HCCs 57 eosinophil count 57 femora 57 chromosome abnormality 57 pulmonary nodules 57 micrograph 57 Doppler echocardiography 57 colorectal neoplasms 57 pulvinar 57 Y chromosomal 57 GNAQ 57 immunocompetent 57 gene MECP2 57 T1 weighted images 57 HLA DRB1 * 57 mesenchyme 57 seminomas 57 immunofluorescence 57 substrate specificity 57 biochemical marker 57 Dpp 57 HLA DQ2 57 MLL2 57 intraepithelial 57 RNA sequences 57 Mutational 57 surgically resected 57 serum TSH 57 hypoperfusion 57 S. mansoni 57 umbilical vein 57 enolase 57 unmethylated 57 ductal 57 CD#c 57 extracapsular extension 57 splenic 57 cytological 57 malignant prostate 57 miR #a [001] 57 genetic polymorphisms 57 IGFBP 57 Chromosomal 57 aneurysmal 57 enteroviral 57 TMPRSS2 ERG 57 R#W [002] 57 radiographic findings 57 morphological traits 57 genomic loci 57 CDKN2A 57 trisomy 57 Haplogroup 57 PCR assay 57 tumorigenicity 57 cystatin C 57 Fig. 2a 57 myogenic 57 CNTNAP2 57 UGT#B# 57 λ 57 HFE gene 57 voxel 57 microsatellite loci 57 Hashimoto thyroiditis 57 insertions deletions 57 apoE 57 ultraconserved elements 57 neuritic 57 splice variants 56 BRCA2 mutation carriers 56 #F FDG 56 matrix metalloproteinase 56 histone modifications 56 S. Typhimurium 56 chromosome #q 56 esophageal carcinoma 56 sexually dimorphic 56 ERalpha 56 aggrecan 56 β1 56 Confocal microscopy 56 bone scintigraphy 56 lactate dehydrogenase LDH 56 rRNA 56 NGAL 56 Gram stain 56 distant metastasis 56 heterochromatic 56 etiologic agent 56 appendiceal 56 BRAF V#E mutation 56 KRAS mutation 56 clade B 56 mitochondrial genomes 56 squamous carcinoma 56 proteomes 56 ADAMTS# 56 Genotypic 56 Fig. 1d 56 acinar 56 Apolipoprotein E 56 pCR 56 polyadenylation 56 lung carcinomas 56 recombination hotspots 56 cellular prion protein 56 percutaneous biopsy 56 mRNA molecules 56 computed tomography scan 56 mtDNA mutations 56 ribosomal DNA 56 Fig. 1c 56 dorsal root ganglion 56 mammary stem cells 56 pituitary adenomas 56 hematoxylin eosin original 56 SOCS3 56 cytologically 56 vacuolar 56 aneuploidy screening 56 parenchymal 56 miRNA genes 56 GFAP 56 gDNA 56 polypoid lesions 56 HGPIN 56 N. gonorrhoeae 56 neoplasms 56 Genetic variation 56 immunohistochemistry IHC 56 ischemic lesions 56 beta globin gene 56 ANCA associated 56 prognostic indicators 56 DEAR1 56 haplogroup 56 antibody titer 56 mitochondrial gene 56 wildtype 56 MDRD 56 cell adhesion molecule 56 CD# + [002] 56 ESR1 56 granulocyte 56 recessive mutation 56 cardiac troponin T 56 dominantly inherited 56 quantitative reverse transcriptase 56 HBV genotype 56 null mice 56 Sgk1 56 hormone receptor status 56 thymoma 56 proximal femur 56 hematological relapse 56 Xenopus laevis 56 SLC#A# gene [001] 56 Fig. 3B 56 chromosomal 56 chromosome rearrangements 56 chimpanzee genomes 56 sonographic 56 erythrocytes 56 metastatic lymph nodes 56 chromosome abnormalities 56 anterior temporal 56 splice junctions 56 abnormal chromosomes 56 lacZ 56 PDGFR alpha 56 erythrocyte sedimentation rate 56 recessive inheritance 56 genetic polymorphism 56 synuclein 56 Brugada syndrome 56 TIMP 1 56 trophoblast cells 56 diffusivity 56 familial clustering 56 malignant lymphoma 56 osteoblastic 56 laterality 56 epithelial ovarian cancer 56 HBsAg 56 metabolite concentrations 56 protein tyrosine phosphatase 56 Fig. 4a 56 malignant lesions 56 eccrine 56 fibroma 56 G allele 56 myxoma 56 cDNA libraries 56 poorer prognosis 56 uPAR 56 bronchoalveolar 56 crystallin 56 ADPKD 56 murine models 56 GPx 56 apolipoprotein E APOE 56 PNET 56 hindbrain 56 dsDNA 56 echogenic foci 56 nucleoli 56 Cyclin E 56 human leukocyte antigen 56 SLC#A# [002] 56 hnRNP 56 carcinoids 56 ductal adenocarcinoma 56 sarcomatoid 56 immunoglobulin genes 56 EGFR gene 56 C#BL 6 mice 56 Ultrasonographic 56 transfected cells 56 neurocognitive function 56 fig. S3 56 nucleotide sequences 56 Alleles 56 T2 weighted MRI 56 telomeric 56 serous ovarian cancer 56 CpG island 56 KRAS oncogene 56 γ 56 malignant neoplasm 56 CD8 + 56 Fig. 4C 56 trabecular 56 mutational analysis 56 Figs. 56 metaphase 56 carcinoembryonic antigen 56 CD#b 56 A. phagocytophilum 56 BRCA1 BRCA2 56 deoxy 56 Apc 56 adipocyte 56 vestibular schwannomas 56 SRY gene 56 TP# mutation 56 untranslated regions 56 MYH9 gene 56 umbilical artery 56 LRRK2 gene 56 morphologies 56 major histocompatibility complex 56 centromeres 56 HLA DRB1 56 immunoblotting 56 seminal vesicles 56 chemosensitivity 56 pancreatic endocrine 56 ALK gene 56 autosomal dominant disorder 56 missense 56 exfoliative glaucoma 56 neurofilament 56 SCr 56 Haptoglobin 56 polycystin 56 T1 weighted 56 hemoglobins 56 N glycan 56 lactate dehydrogenase 56 CD# expression [001] 56 #β estradiol 56 ER alpha 56 microvessel density 56 mutated K ras 56 valine 56 distinct subtypes 56 Supplementary Figs 56 apolipoprotein 56 CYP#B# 56 Quantitative RT PCR 56 lateral radiographs 56 malignant transformation 56 PDGF B 56 microRNA molecules 56 lobule 56 demyelinating 56 prognostic indicator 56 MDCK cells 56 varicocele 56 Clusterin 56 SLC#A# [001] 56 agarose gel electrophoresis 56 spontaneous mutation 56 number variation CNV 56 KRAS BRAF 56 Sjögren syndrome 56 biochemical recurrence 56 Her2 gene 56 Phenotypic 56 FDG-PET/CT 56 β thalassemia 56 db db mice 56 APOE gene 56 Lymph node 56 isoprostane 56 transesophageal echocardiography 56 paraffin embedded tissue 56 MTT assay 56 RNA polymerases 56 operons 56 Hurthle cell 56 chromosome #p#.# 56 virologic responses 56 thyroid nodules 56 papillary RCC 56 pT3 56 leukocyte count 56 amphioxus 56 Cx# [001] 56 hepatic metastasis 56 activin 56 maternal serum 56 pT2 56 histological examination 56 chemoresistant 56 osteopenic 56 renal cortical 56 Morphological 56 noncoding 56 viral nucleic acids 56 Alu elements 56 brain lesions 56 microarray experiments 56 leptin receptor 56 leukemic cell 56 At#g# 56 HMPV 56 colorectal adenocarcinoma 56 ovarian carcinoma 56 PTEN protein 56 gene loci 56 GenBank accession 56 transmural 56 node metastases 56 sonographic diagnosis 56 ependymoma 56 meiotic recombination 56 chromosomally 56 renal cell carcinomas 56 Legg Calvé Perthes disease 56 AMACR 56 immunofluorescence microscopy 56 CD# expression [002] 56 pre eclamptic 56 vertebrate embryos 56 clefting 56 ultrastructure 56 distal femur 56 N Myc 56 lymphangiogenesis 56 Insulin sensitivity 56 astrocytic 56 microRNAs miRNAs 56 QTLs 56 NR#A# gene 56 myocyte 55 carcinoid 55 efferent 55 endonuclease 55 histone acetylation 55 white matter hyperintensities 55 germline cells 55 surrogate markers 55 nondiagnostic 55 sexual dimorphism 55 CFH gene 55 cerebellar 55 hypervascular

Back to home page